Cargando…
CRISPR/Cas9—Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development
The clustered regularly interspaced short palindromic repeat (CRISPR)/associated protein 9 (Cas9) technology is revolutionizing genome editing approaches. Its high efficiency, specificity, versatility, flexibility, simplicity and low cost have made the CRISPR/Cas9 system preferable to other guided s...
Autores principales: | Okoli, Arinze, Okeke, Malachy I., Tryland, Morten, Moens, Ugo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795463/ https://www.ncbi.nlm.nih.gov/pubmed/29361752 http://dx.doi.org/10.3390/v10010050 |
Ejemplares similares
-
Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?
por: Okeke, Malachy I., et al.
Publicado: (2017) -
Molecular characterization and phylogenetics of Fennoscandian cowpox virus isolates based on the p4c and atip genes
por: Okeke, Malachy Ifeanyi, et al.
Publicado: (2014) -
Orthopoxvirus DNA in Eurasian Lynx, Sweden
por: Tryland, Morten, et al.
Publicado: (2011) -
In vitro host range, multiplication and virion forms of recombinant viruses obtained from co-infection in vitro with a vaccinia-vectored influenza vaccine and a naturally occurring cowpox virus isolate
por: Okeke, Malachy Ifeanyi, et al.
Publicado: (2009) -
CRISPR/Cas9 as an antiviral against Orthopoxviruses using an AAV vector
por: Siegrist, Cathryn M., et al.
Publicado: (2020)